Top News

WHO Launches Biosimilar Pilot Program

May 05, 2017

The program aims to make biosimilars for the treatment of cancer more widely available in middle- and low-income countries.

US Prescription Drug Spending to Hit $610 billion in 2021, according to Quintiles/IMS

May 05, 2017

Forecasts were lowered, Reuters reported, due to reduced drug approvals and increased competitive pressures.

FDA Warns 14 Companies for Sale of Fraudulent Cancer Treatments

May 01, 2017

The agency has issued more than 90 warning letters over the past 10 years to companies selling fraudulent cancer treatments.

UC Berkeley Appeals CRISPR Decision

April 13, 2017

UC Berkeley appealed the February 2017 decision that determined Harvard and MIT’s Broad Institute and Berkeley’s CRISPR-Cas9 technologies were separately patentable.

Drug Approvals in 2016: Europe vs. US

April 07, 2017

A drop in US drug approvals was noted but this trend was not yet seen in Europe.

GlaxoSmithKline Recalls 600,000 Asthma Inhalers in US

April 07, 2017

The recall was issued because of a defective delivery system; the units affected had possible package leakage.

FDA Approves First Treatment for Primary-Progressive Forms of Multiple Sclerosis

March 29, 2017

The mAb is the first approved treatment that targets the progressive form of the disease.

Researchers Discover Structure and Mechanism of Human Antibody for Zika Virus

March 16, 2017

Human antibody for Zika virus could help in the treatment and prevention of the infection.

Gottlieb to Face User Fees, De-Regulation Pressures

March 13, 2017

Trump’s choice for FDA commissioner faces drug pricing, regulatory, and approval challenges.

Trump Nominates Scott Gottlieb to Lead FDA

March 10, 2017

The White House said President Trump will nominate Scott Gottlieb to the position of FDA commissioner.